Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy
Published: 28 February 2025| Version 1 | DOI: 10.17632/d9ngfbjxp3.1
Contributors:
, , , , Description
Supplemental figure 1 relative survival by year of diagnosis and extent of MCC at presentation. Supplemental figure 2 24-month overall survival by year of diagnosis and extent of Merkel cell carcinoma at presentation.
Files
Institutions
- University of WashingtonWA, Seattle
- Swedish Cancer InstituteWA, Seattle
- Fred Hutchinson Cancer Research CenterWA, Seattle
- Washington State UniversityWA, Pullman
Categories
Epidemiology, Oncology, Merkel Cell Carcinoma, Survival Analysis, Immunotherapy, Database
Funders
- Prostate Cancer FoundationCalifornia, United StatesGrant ID: Kelsey Dickson Team Science Courage Research Award
- Washington State UniversityWashington, United StatesGrant ID: Paul G. Allen Research Center at Swedish Cancer Institute, Swedish Cancer Institute Foundation